Stock Fundamentals

Company Information

Company Name
Editas Medicine Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US28106W1036
CIK: 0001650664
CUSIP: 28106W103
Currency: USD
Full Time Employees: 87
Phone: 617 401 9000
Fiscal Year End: December
IPO Date: Feb 03, 2016
Description:

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Address:

11 Hurley Street, Cambridge, MA, United States, 02141

Directors & Officers

Name Title Year Born
Dr. Gilmore O'Neill M.D. President, CEO & Director 1964
Ms. Amy Parison Senior VP & CFO 1986
Dr. Linda C. Burkly Ph.D. Executive VP & Chief Scientific Officer 1957
Dr. Feng Zhang Ph.D. Co-Founder & Scientific Advisory Board Member NA
Dr. George McDonald Church Ph.D. Co-Founder & Scientific Advisory Board Member 1954
Mr. Gregory Whitehead Executive VP and Chief Technical & Quality Officer NA
Mr. Damien Grierson J.D. Senior VP, General Counsel & Corporate Secretary NA
Mr. Tom Love Vice President of People NA
Mr. Frank Panaccio Senior VP & Chief Business Officer NA
Ms. Brieana Buckley Senior Vice President of Development and Program Leadership NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 03, 2026 Amy Parison N/A Sale 474.00 $2.02 $957.48
Mar 03, 2026 Gilmore Neil O'neill N/A Sale 5.39K $2.02 $10.90K
Mar 03, 2026 Linda Burkly N/A Sale 749.00 $2.02 $1.51K
Dec 03, 2025 Amy Parison N/A Sale 461.00 $2.15 $991.15
Dec 03, 2025 Gilmore Neil O'neill N/A Sale 5.60K $2.15 $12.05K
Dec 03, 2025 Linda Burkly N/A Sale 713.00 $2.15 $1.53K
Aug 07, 2025 Amy Parison N/A Sale 679.00 $2.58 $1.75K
Jul 31, 2025 Linda Burkly N/A Sale 5.12K $2.49 $12.75K
Jun 03, 2025 Amy Parison N/A Sale 446.00 $1.72 $767.12
Jun 03, 2025 Gilmore Neil O'neill N/A Sale 15.19K $1.72 $26.13K
Jun 03, 2025 Linda Burkly N/A Sale 726.00 $1.72 $1.25K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 9.26M Mar 31, 2026 6.04% $0.00 -0.90%
Vanguard Group Inc 8.21M Dec 31, 2025 5.35% $0.00 17.84%
Vanguard Capital Management, LLC 4.20M Mar 31, 2026 2.74% $0.00 0.00%
Renaissance Technologies Corp 3.97M Mar 31, 2026 2.59% $0.02 30.67%
Vanguard Portfolio Management, LLC 3.15M Mar 31, 2026 2.05% $0.00 0.00%
Geode Capital Management, LLC 2.31M Mar 31, 2026 1.51% $0.00 1.18%
State Street Corp 2.08M Mar 31, 2026 1.35% $0.00 5.12%
Nuveen, LLC 1.98M Mar 31, 2026 1.29% $0.00 0.03%
JPMorgan Chase & Co 1.95M Mar 31, 2026 1.27% $0.00 148.68%
D. E. Shaw & Co LP 1.94M Mar 31, 2026 1.27% $0.00 75.19%
Opaleye Management Inc 1.93M Mar 31, 2026 1.26% $0.63 0.00%
Two Sigma Investments LLC 1.55M Mar 31, 2026 1.01% $0.00 -5.12%
Acadian Asset Management LLC 1.46M Mar 31, 2026 0.95% $0.01 1,426.31%
AQR Capital Management LLC 1.37M Mar 31, 2026 0.89% $0.00 112.75%
Two Sigma Advisers, LLC 1.22M Dec 31, 2025 0.80% $0.00 1.59%
Kennedy Capital Management Inc 1.05M Mar 31, 2026 0.69% $0.06 87.22%
Charles Schwab Investment Management Inc 861.33K Mar 31, 2026 0.56% $0.00 8.39%
Northern Trust Corp 742.44K Mar 31, 2026 0.48% $0.00 12.07%
Mackenzie Investments 730.05K Mar 31, 2026 0.48% $0.00 0.00%
Citadel Advisors Llc 662.39K Mar 31, 2026 0.43% $0.00 -19.32%

Shares Statistics

Shares Outstanding: 153.46M
Shares Float: 79.28M
% Insiders: 17.10%
% Institutions: 4,924.00%
Short % Float: 9.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 3.02M 1.97% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 2.39M 1.56% ▲ 0.93% May 29, 2026
3 Vanguard Strategic Equity Inv 1.87M 1.22% ▲ 0.00% Mar 31, 2026
4 Nuveen Quant Small Cap Equity R6 1.68M 1.09% ▲ 0.00% Apr 30, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 1.10M 0.72% ▲ 2.08% Apr 30, 2026
6 Kennedy Micro Cap 1.05M 0.69% ▲ 87.22% Mar 31, 2026
7 Selectra J. Lamarck Biotech A 988.06K 0.64% ▲ 0.00% May 31, 2026
8 Fidelity Small Cap Index 964.23K 0.63% ▲ 8.56% Mar 31, 2026
9 iShares Russell 2000 Value ETF 844.36K 0.55% ▲ 0.00% May 29, 2026
10 iShares Biotechnology ETF 714.44K 0.47% ▲ 1.95% May 29, 2026

Valuation Metrics

Enterprise Value: $269.63M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $371.38M
EBITDA: $-85.19M
PEG Ratio: $0.00
Book Value: $0.05
Earnings/Share: $-1.14
Profit Margin: -281.59%
Operating Margin: -883.19%
ROA (TTM): -26.95%
ROE (TTM): -326.07%
Revenue (TTM): $38.69M
Revenue/Share (TTM): $0.42
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -39.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.54x 0.40x 0.85x -16.10x -0.07x
2024-12-31 3.75x 0.11x 0.61x -114.68x -0.06x
2023-12-31 5.39x 0.07x 0.30x N/A -0.16x
2022-12-31 5.94x 0.03x 0.30x -53.48x -0.05x
2021-12-31 10.82x 0.02x 0.18x -33.90x -0.05x
2020-12-31 7.20x 0.02x 0.31x -51.76x -0.05x
2019-12-31 7.74x 0.02x 0.48x -19.27x -0.04x
2018-12-31 10.44x 0.05x 0.44x -33.01x -0.12x
2017-12-31 9.05x 0.20x 0.44x -122.63x -0.35x
2016-12-31 5.66x 0.34x 0.41x -1,567.55x -0.47x
2015-12-31 20.94x -0.54x 1.56x -246.94x -0.62x
2014-12-31 1.74x -0.03x 2.25x -374.21x -0.03x
2013-12-31 0.98x 0.00x 1.71x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about EDIT.US!